Orion Pharma

Photo: Courtesy
Corporates

Orion Pharma organizes Raffle Draw for doctors' poetry writing  competition 

Logo of BSEC/File photo
Stocks

Anwar Galvanizing, Renata, Orion Pharma now come out of floor restriction

Orion Pharma awards the winners of ICC MEN’S Cricket World Cup 2023 quiz contest at Orion House on Saturday (25 November). Photo: Courtesy
Corporates

Orion Pharma awards 5 doctors for winning Cricket World Cup quiz contest

Arzuda Karim, Company Director and Trustee of Orion Pharma Welfare Trust, presided over the event attended by Managing Director of Orion Pharma Ltd Zareen Karim, Executive Director SM Noor Hossain and other senior officials of the company. PHOTO: COURTESY
Corporates

Orion Pharma offers scholarship to poor medical students

Orion releases third quarter financial statements
PSI

Orion releases third quarter financial statements

Orion Pharma greets FCPS doctors
Corporates

Orion Pharma greets FCPS doctors

Orion Pharma: Un-Audited Half Yearly (Q2) Financial Statements
PSI

Orion Pharma: Un-Audited Half Yearly (Q2) Financial Statements

Managing Director of Orion Pharma Zareen Karim, Executive Director SM Noor Hossain, Bangabandhu Sheikh Mujib Medical University Vice-chancellor Prof Dr Md Sharfuddin Ahmed, former Bangladeshi footballer Sheikh Mohammad Aslam, and other officials pose for a photograph at the raffle draw of the Football World Cup 2022 quiz contest organised by the company. PHOTO: COURTESY
Corporates

Orion Pharma awards 5 doctors for winning Football World Cup quiz contest

Photo: Courtesy
Corporates

Orion Pharma holds strategic meeting for 2023

Orion Pharma: Price Sensitive Information
PSI

Orion Pharma: Price Sensitive Information

Orion Pharma: Un-audited half yearly (Q2) financial statements
PSI

Orion Pharma: Un-audited half yearly (Q2) financial statements

Orion Pharma approves 12% cash dividend
Stocks

Orion Pharma approves 12% cash dividend

Orion Pharma: Unaudited 1st quarterly financial statement
PSI

Orion Pharma: Unaudited 1st quarterly financial statement